HomeSHTDY • OTCMKTS
add
Sinopharm Group ADR
Nakaraang pagsara
$11.10
Sakop ng taon
$10.13 - $16.31
Market cap
57.05B HKD
Average na Volume
26.79K
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (CNY) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 144.89B | -3.82% |
Gastos sa pagpapatakbo | 6.44B | 15.96% |
Net na kita | 1.67B | -43.43% |
Net profit margin | 1.15 | -41.33% |
Kita sa bawat share | — | — |
EBITDA | 5.32B | -35.75% |
Aktuwal na % ng binabayarang buwis | 29.36% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CNY) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 54.31B | -19.10% |
Kabuuang asset | 392.83B | 2.46% |
Kabuuang sagutin | 266.14B | 1.17% |
Kabuuang equity | 126.69B | — |
Natitirang share | 3.12B | — |
Presyo para makapag-book | 0.44 | — |
Return on assets | 3.00% | — |
Return on capital | 5.81% | — |
Cash Flow
Net change in cash
| (CNY) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 1.67B | -43.43% |
Cash mula sa mga operasyon | 26.27B | 43.57% |
Cash mula sa pag-invest | -1.36B | 69.47% |
Cash mula sa financing | -19.42B | -266.23% |
Net change in cash | 5.49B | -78.50% |
Malayang cash flow | 3.14B | -92.00% |
Tungkol
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
Itinatag
2003
Website
Mga Empleyado
108,217
